Overview
Ana Glembotsky practices practicing medicine in Buenos Aires, Argentina.
Ms. Glembotsky is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Gray Platelet Syndrome, Thrombocytopenia, RUNX1 Familial Platelet Disorder, and Blood Clots.
She is actively involved in clinical research, co-authoring 36 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ana C. Glembotsky
Is Ana C. Glembotsky a top-rated expert for Gray Platelet Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Ana C. Glembotsky is classified as an Elite expert for Gray Platelet Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ana C. Glembotsky participate in research or clinical trials?
Yes. Ana C. Glembotsky has published 36 articles and abstracts on conditions like Gray Platelet Syndrome. You can view a list of Ana C. Glembotsky's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Gray Platelet SyndromeMs. Glembotsky isElite. Learn about Gray Platelet Syndrome.
- Advanced
- RUNX1 Familial Platelet DisorderMs. Glembotsky isAdvanced. Learn about RUNX1 Familial Platelet Disorder.
- ThrombocytopeniaMs. Glembotsky isAdvanced. Learn about Thrombocytopenia.
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Glembotsky isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaMs. Glembotsky isExperienced. Learn about Adult Immune Thrombocytopenia.
- Bernard-Soulier SyndromeMs. Glembotsky isExperienced. Learn about Bernard-Soulier Syndrome.
- Blood ClotsMs. Glembotsky isExperienced. Learn about Blood Clots.
- Essential ThrombocythemiaMs. Glembotsky isExperienced. Learn about Essential Thrombocythemia.
- Immune Thrombocytopenic Purpura (ITP)Ms. Glembotsky isExperienced. Learn about Immune Thrombocytopenic Purpura (ITP).
- LeukemiaMs. Glembotsky isExperienced. Learn about Leukemia.
- MosaicismMs. Glembotsky isExperienced. Learn about Mosaicism.
- MyelofibrosisMs. Glembotsky isExperienced. Learn about Myelofibrosis.
- Myeloproliferative Neoplasms (MPN)Ms. Glembotsky isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- PurpuraMs. Glembotsky isExperienced. Learn about Purpura.
- SplenomegalyMs. Glembotsky isExperienced. Learn about Splenomegaly.
- Von Willebrand Disease (VWD)Ms. Glembotsky isExperienced. Learn about Von Willebrand Disease (VWD).